Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:29 PM
Ignite Modification Date:
2025-12-24 @ 10:29 PM
NCT ID:
NCT03000335
Eligibility Criteria:
Inclusion Criteria:
* Written inform consent was given for the clinical trial by the subject or subject's legally acceptable representative.
* Patient with a final diagnosis of B-ALL
* Male or Female
* Age from 2 to 19 years at diagnosis.
* Patient during remission at least 3 months after starting treatment.
* Patient is up to five years from diagnosis at the baseline visit.
* Patient at relapse before starting treatment for relapse.
* Patient weighs at least 9.4 kg.
Exclusion Criteria:
* Discovery of an alternative disorder other than B-cell acute lymphoblastic leukemia.
* The subject has known human immunodeficiency virus (HIV), hepatitis B surface antigen, or hepatitis C antibody or other dangerous contagious disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
2 Years
Maximum Age:
19 Years
Study:
NCT03000335
Study Brief:
Protocol Section:
NCT03000335